what is microdose of semaglutide Microdosing Semaglutide: Does It Work for Weight Loss? What Is Tirzepatide Microdosing &
Description
Cerf, M
Summary Dizziness is a common semaglutide side effect, with a 2025 real-world cohort reporting 15% of patients experienced dizziness after starting treatment, and many episodes occur in the evening or persist after gastrointestinal symptoms ease
NICE recommends semaglutide 2.4 mg (Wegovy) for eligible adults with obesity, and tirzepatide (Mounjaro) has received MHRA marketing authorisation
The key is matching needle length to the subcutaneous depth at your chosen injection site
A qualified provider can interpret these biomarkers alongside your mental health history to predict tolerability
More people stay on it
